XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina

Name: XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina
Uploaded: Indegene Archive
Description: XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina. Albert Gianchetti, CEO, XyloCor Therapeutics shares his thoughts in this video

May 2020 · Market Access

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina. Albert Gianchetti, CEO, XyloCor Therapeutics shares his thoughts in this video

Explore additional video categories

Analytics
Biotech
Clinical
Commercial
Corporate

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina

About this video